Afya Limited · NASDAQ (us_market)
Consumer Defensive · Education & Training Services · Brazil
Afya Limited operates as a medical education group in Brazil. The company operates in three segments: Undergraduate, Continuing Education, and Medical Practice Solutions. The Undergraduate segment offers educational services through undergraduate courses related to medical school, health sciences, and other non-health undergraduate programs, including medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, biomedicine, business administration, accounting, law, civil and industrial engineering, and pedagogy. The Continuing Education segment provides medical education, including residency preparation programs, specialization test preparation, graduate courses in medicine, and digital and in-person professional development for physicians and medical students. The Medical Practice Solutions segment offers clinical decision support platforms, medical practice management software, healthcare financial services, and digital healthcare ecosystem solutions, such as electronic medical records, practice management tools, telemedicine, digital prescriptions, and doctor-patient relationship platforms. This segment also provides a subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. The company also offers educational health and medical imaging; and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. In addition, it offers printed and digital content, as well as an online medical education platform and physicians, healthcare professionals and students. Afya Limited was founded in 1999 and is headquartered in Belo Horizonte, Brazil.
| Event Period | Drawdown | Buy Point (Bottom) | Sell Point (Peak) | ticker.setupCols.buyScore | ticker.setupCols.sellScore | Max Return | Algo Return |
|---|---|---|---|---|---|---|---|
DROP2026-02-09$15.64 RISE2026-03-03$13.16 PEAK2026-04-17$15.86 67d | -15.9% 22d | Missed | Missed | — | — | +20.5% 45d | Missed |
DROP2025-09-24$16.32 RISE2026-01-20$13.66 PEAK2026-04-16$15.75 204d | -16.3% 118d | Missed | Missed | — | — | +15.3% 86d | Missed |
DROP2025-05-09$19.61 RISE2025-08-01$13.68 PEAK2025-09-24$16.32 138d | -30.2% 84d | Missed | Missed | — | — | +19.3% 54d | Missed |
DROP2024-08-15$18.92 RISE2024-12-18$14.58 PEAK2025-03-14$18.03 211d | -22.9% 125d | Missed | Missed | — | — | +23.7% 86d | Missed |
DROP2024-03-18$21.69 RISE2024-06-04$15.76 PEAK2024-08-15$18.92 150d | -27.3% 78d | Missed | Missed | — | — | +20.1% 72d | Missed |
DROP2024-01-19$22.37 RISE2024-04-19$16.02 PEAK2024-05-20$19.81 122d | -28.4% 91d | Missed | Missed | — | — | +23.7% 31d | Missed |
DROP2022-11-11$16.28 RISE2023-03-23$9.96 PEAK2023-04-14$13.54 154d | -38.8% 132d | Missed | Missed | — | — | +35.9% 22d | Missed |
DROP2022-10-04$15.16 RISE2022-10-20$12.32 PEAK2022-11-11$16.28 38d | -18.7% 16d | Missed | Missed | — | — | +32.1% 22d | Missed |
DROP2022-03-24$15.89 RISE2022-07-12$9.02 PEAK2022-10-04$15.16 194d | -43.2% 110d | Missed | Missed | — | — | +68.1% 84d | Missed |
DROP2022-03-24$15.89 RISE2022-07-11$9.02 PEAK2022-10-04$15.16 194d | -43.2% 109d | Missed | Missed | — | — | +68.1% 85d | Missed |
DROP2021-10-28$17.74 RISE2022-03-07$11.73 PEAK2022-03-24$15.89 147d | -33.9% 130d | Missed | Missed | — | — | +35.5% 17d | Missed |
DROP2021-09-17$22.06 RISE2022-01-24$12.52 PEAK2022-03-24$15.89 188d | -43.2% 129d | Missed | Missed | — | — | +26.9% 59d | Missed |
DROP2021-09-14$22.38 RISE2022-01-21$12.52 PEAK2022-03-24$15.89 191d | -44.1% 129d | Missed | Missed | — | — | +26.9% 62d | Missed |
DROP2021-07-20$25.20 RISE2021-11-23$12.77 PEAK2021-12-30$15.96 163d | -49.3% 126d | Missed | Missed | — | — | +25.0% 37d | Missed |
DROP2020-11-24$28.32 RISE2021-03-31$18.59 PEAK2021-06-24$27.84 212d | -34.4% 127d | Missed | Missed | — | — | +49.8% 85d | Missed |
1–15 / 17 1 / 2 | |||||||
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
The average of price targets set by Wall Street analysts indicates a potential upside of 25.6% in Afya (AFYA). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
AFYA Ltd passes the "Caviar Cruise" quality screen with a 54% ROIC, strong cash flow, and a low P/E of 7.46, making it a candidate for long-term, quality-focused investors.
Nomad Foods is a leading European frozen foods producer with a broad portfolio of well-known brands sold across major supermarket chains.
AFYA vs. APEI: Which Stock Is the Better Value Option?
The United States market has experienced a robust performance, rising 1.5% over the last week and climbing 26% in the past year, with earnings projected to grow by 17% annually. In this favorable environment, selecting dividend stocks that offer consistent payouts and potential for growth can be an effective strategy for investors seeking stable returns.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Afya Ltd (AFYA) reports robust financial performance with an 8% revenue increase, while navigating challenges in the Medical Practice Solutions segment.
Afya (NASDAQ:AFYA) affirms FY2026 sales outlook from $731.710 million-$759.496 million to $731.710 million-$759.496 million vs $760.310 million estimate.
Afya (NASDAQ:AFYA) reported quarterly earnings of $0.55 per share which beat the analyst consensus estimate of $0.54 by 1.85 percent. This is a 82.81 percent decrease over earnings of $3.20 per share from the same period
BELO HORIZONTE, Brazil — BELO HORIZONTE, Brazil — Afya Ltd. on Thursday reported first-quarter earnings of $48.8 million. On a per-share basis, the Belo Horizonte, Brazil-based company said...
Afya Limited (AFYA) Q1 2026 Earnings Call May 7, 2026 5:00 PM EDTCompany ParticipantsRenata Couto - Investor Relations Executive ManagerVirgilio Deloy...
Presenter SpeechRenata Couto Thank you for joining us for Afya's conference call. I'm here today with Afya's CEO, Virgilio Gibbon; and our CFO, Luis Andre Blanco. During today's presentation, our...
Afya (NASDAQ:AFYA) executives highlighted revenue growth, steady margins in core undergraduate operations, and continued investment in its digital medical practice tools during the company’s first-quarter 2026 earnings call. CEO Virgilio Gibbon and CFO Luis Blanco also addressed investor questions o
2026-05-07. The following slide deck was published by Afya Limited in conjunction with their 2026 Q1 earnings call.
Solid Start to 2026 with Disciplined ExecutionShareholder Value Creation...
Read our monthly compilation of dividend stock picks based on the Graham Value Formula -- access May's list here.
Afya stock performance context Afya (NasdaqGS:AFYA) has been drawing investor attention after a period in which the stock showed a 6.6% decline over the past month and a 6.2% decline over the past 3 months. See our latest analysis for Afya. That recent 6.6% 1 month share price decline sits alongside a year to date share price return of 6.5% decline and a 1 year total shareholder return of 23% decline, so shorter term momentum looks weaker even though the 3 year total shareholder return stands...
Afya Limited , the leading medical education group and medical practice solutions provider in Brazil, announced today that Moody’s reaffirmed Afya’s credit rating at AAA.br and maintained a...
JP Morgan analyst Marcelo Santos maintains Afya (NASDAQ:AFYA) with a Neutral and lowers the price target from $22 to $21.5.
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| AFYA | +0.86% | +4.40% | -9.09% | -23.15% |
| XLP | -1.50% | -6.54% | +6.73% | +0.10% |
| Alpha (stock − sector) | +2.36% | +10.93% | -15.82% | -23.25% |
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| FidelityFMR | fundamental | 2.70M | $40.18M | 0.00% | Trimmed-1.2% | 2026-03-31 |
| RenTech | quant | 379.0K | $5.64M | 0.01% | Trimmed-15.0% | 2026-03-31 |
| TwoSigma | quant | 322.3K | $4.79M | 0.00% | Added+82.7% | 2026-03-31 |
| StateStreet | passive | 129.0K | $2.00M | 0.00% | Added+1.7% | 2026-03-31 |
| DEShaw | quant | 104.5K | $1.55M | 0.00% | Trimmed-31.5% | 2026-03-31 |
| Wellington | fundamental | 40.8K | $606.35K | 0.00% | Trimmed-21.9% | 2026-03-31 |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-08-13upcoming | 2.15 | — | — |
| 2026-05-07 | 2.91 | 2.85 | -2.13% |
| 2026-03-12 | 1.87 | 2.25 | +20.11% |
| 2025-11-12 | 1.77 | 2.08 | +17.32% |
| 2025-08-13 | 2.02 | 2.27 | +12.47% |
| 2025-05-08 | 2.64 | 3.20 | +21.13% |
| 2025-03-13 | 1.81 | 2.10 | +15.90% |
| 2024-11-13 | 1.58 | 1.31 | -17.13% |
| 2024-08-14 | 1.95 | 2.29 | +17.46% |
| 2024-05-09 | 2.36 | 2.74 | +16.02% |
| 2024-03-14 | 1.55 | 1.79 | +15.49% |
| 2023-11-13 | 1.36 | 1.38 | +1.84% |
| 2023-08-28 | 1.30 | 1.42 | +9.64% |
| 2023-05-24 | 1.58 | 1.77 | +12.37% |
| 2023-03-22 | 1.42 | 1.38 | -2.49% |
| 2022-11-21 | 1.30 | 1.28 | -1.31% |